Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product

Phenobarbital
FDA is asked to order recall of unapproved phenobarbital sodium products • Source: Shutterstock

More from US FDA

More from Agency Leadership